Three research teams have been selected as recipients of the 2024 Blavatnik Therapeutics Challenge Awards, an annual awards ...

Artificial Intelligence is already being used in clinics to help analyze imaging data, such as X-rays and scans. But the recent arrival of sophisticated large-language AI models on the scene is ...

Three key players share the story of how fundamental discoveries in the laboratory became a first-of-its-kind therapy that promises to have a monumental impact on sickle cell disease patients around ...

Two faculty members from Harvard Medical School are among the 65 newly elected fellows of the American Academy of Microbiology, the honorific leadership group within the American Society for ...

Team that performed first-of-its-kind surgery in 2024 has successfully transplanted another genetically edited pig kidney into a living person. The patient — the fourth worldwide to receive a pig ...

Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own tissues. The protein, called granzyme K, whose role until now was unclear, ...

When Vijay Sankaran was an MD-PhD student at Harvard Medical School, a patient helped inspire him to study the genetics of sickle cell disease alongside his mentor, Stuart H. Orkin, in a laboratory at ...

Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...

Behind every new drug or vaccine is a journey. It often begins with curiosity. As researchers seek to understand the biological and chemical underpinnings of disease, they generate knowledge that ...

Alvin Francis Poussaint, professor of psychiatry, emeritus, at Harvard Medical School, died on Feb. 24 at age 90 after a ...